Corvus Pharmaceuticals, Inc. - stock earnings
CRVS Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -6.7 million USD | ? USD |
| 2023Q3 | -6.0 million USD | ? USD |
| 2023Q2 | -6.5 million USD | ? USD |
| 2023Q1 | -8.8 million USD | ? USD |
| 2022Q4 | -16.2 million USD | ? USD |
| 2022Q3 | -14.6 million USD | ? USD |
| 2022Q2 | -8.3 million USD | ? USD |
| 2022Q1 | -9.2 million USD | ? USD |
| 2021Q4 | -9.2 million USD | ? USD |
| 2021Q3 | -10.7 million USD | ? USD |
| 2021Q2 | -11.8 million USD | ? USD |
| 2021Q1 | -11.6 million USD | ? USD |
| 2020Q4 | 27.3 million USD | ? USD |
| 2020Q3 | -9.8 million USD | ? USD |
| 2020Q2 | -10.6 million USD | ? USD |
| 2020Q1 | -12.9 million USD | ? USD |
| 2019Q4 | -11.0 million USD | ? USD |
| 2019Q3 | -11.0 million USD | ? USD |
| 2019Q2 | -13.0 million USD | ? USD |
| 2019Q1 | -11.6 million USD | ? USD |
| 2018Q4 | -10.5 million USD | ? USD |
| 2018Q3 | -10.5 million USD | ? USD |
| 2018Q2 | -11.6 million USD | ? USD |
| 2018Q1 | -14.3 million USD | ? USD |
| 2017Q4 | -11.9 million USD | ? USD |
| 2017Q3 | -12.7 million USD | ? USD |
| 2017Q2 | -15.0 million USD | ? USD |
| 2017Q1 | -16.0 million USD | ? USD |
| 2016Q4 | -11.1 million USD | ? USD |
| 2016Q3 | -10.3 million USD | ? USD |
| 2016Q2 | -8.6 million USD | ? USD |
| 2016Q1 | -6.3 million USD | ? USD |
| 2015Q4 | -6.0 million USD | ? USD |
| 2015Q3 | -3.2 million USD | ? USD |
| 2015Q2 | -20.2 million USD | ? USD |
| 2015Q1 | -1.9 million USD | ? USD |
| 2014Q4 | -175636 USD | ? USD |
CRVS Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -27.0 million USD | ? USD |
| 2022 | -50.0 million USD | ? USD |
| 2021 | -38.2 million USD | ? USD |
| 2020 | -4.8 million USD | ? USD |
| 2019 | -43.7 million USD | ? USD |
| 2018 | -46.9 million USD | ? USD |
| 2017 | -55.7 million USD | ? USD |
| 2016 | -36.4 million USD | ? USD |
| 2015 | -31.3 million USD | ? USD |
| 2014 | -175636 USD | ? USD |
CRVS
Price: $1.99
52 week price:
Earnings Per Share: -0.56 USD
P/E Ratio: -3.23
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 47000
Ebitda: -12.7 millionMarket Capitalization: 82.4 million